Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial

Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial

Abstract Acute decompensated heart failure (ADHF) is the leading cause of hospitalization in patients aged 65 years or older, and most of them present with congestion. The use of hydrochlorothiazide (HCTZ) may increase the response to loop diuretics. To evaluate the effect of adding HCTZ to furosemi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Diogo Silva Piardi, Maurício Butzke, Ana Carolina Martins Mazzuca, Bruna Sessim Gomes, Sofia Giusti Alves, Bruno Jaskulski Kotzian, Eduarda Chiesa Ghisleni, Vanessa Giaretta, Priscila Bellaver, Gabrielle Aguiar Varaschin, Arthur Pereira Garbin, Luís Beck-da-Silva
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f3a183176446485bb7e0fb0736a57c05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f3a183176446485bb7e0fb0736a57c05

Ejemplares similares